BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6733584)

  • 1. Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI.rCi.
    Singh G; Renton KW
    Can J Physiol Pharmacol; 1984 Apr; 62(4):379-83. PubMed ID: 6733584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of cytochrome P450-dependent drug biotransformation by poly(rI.rC) and aspirin.
    Jagota SK
    Biochem Med Metab Biol; 1989 Jun; 41(3):212-6. PubMed ID: 2472829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the interferon inducing agents tilorone and polyriboinosinic acid . polyribocytidylic acid (poly IC) on the hepatic monooxygenase systems of pregnant and fetal rats.
    Robbins MS; Mannering GJ
    Biochem Pharmacol; 1984 Apr; 33(8):1213-22. PubMed ID: 6712731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for xanthine oxidase in the loss of cytochrome P-450 evoked by interferon.
    Moochhala SM; Renton KW
    Can J Physiol Pharmacol; 1991 Jul; 69(7):944-50. PubMed ID: 1720069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressant effects of the interferon inducer polyriboinosinic:polyribocytidylic acid on cytochrome P-450 hemoproteins.
    Zerkle TB; Wade AE
    Pharmacology; 1984; 28(1):1-11. PubMed ID: 6322211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of polyriboinosinic:polyribocytidylic acid-induced depression of mouse hepatic mixed function oxidases by actinomycin D or cycloheximide.
    Gorce P; Wade AE
    Biochem Biophys Res Commun; 1984 May; 121(1):237-42. PubMed ID: 6732804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC.
    Morgan ET
    Biochem Pharmacol; 1991 Jun; 42(1):51-7. PubMed ID: 2069598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of aging and poly IC treatment on xenobiotic metabolism in mice.
    Ali B; Walford RL; Imamura T
    Life Sci; 1985 Oct; 37(15):1387-93. PubMed ID: 4046739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a microsomal cytochrome P-450 with high activity of coumarin 7-hydroxylase from mouse liver.
    Kaipainen P; Nebert DW; Lang MA
    Eur J Biochem; 1984 Nov; 144(3):425-31. PubMed ID: 6436023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the inductive effects of phenobarbital and 3-methylcholanthrene on ascorbic acid synthesis and hepatic cytochrome P-450-linked monooxygenase systems by the interferon inducers, poly rI.rC and tilorone.
    Renton KW; Keyler DE; Mannering GJ
    Biochem Biophys Res Commun; 1979 Jun; 88(3):1017-23. PubMed ID: 465068
    [No Abstract]   [Full Text] [Related]  

  • 11. The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI . rC).
    Renton KW; Dickson G
    Toxicol Appl Pharmacol; 1984 Jan; 72(1):40-5. PubMed ID: 6710483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid.
    Knickle LC; Spencer DF; Renton KW
    Biochem Pharmacol; 1992 Aug; 44(3):604-8. PubMed ID: 1380810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction by kopsinine of hepatic mixed-function oxidase in mice].
    Huang WY; Liu GT
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):264-8. PubMed ID: 2088003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the interferon inducing agents tilorone and polyriboinosinic acid . polyribocytidylic acid (poly IC) on the hepatic monooxygenase systems of the developing neonatal rat.
    Robbins MS; Mannering GJ
    Biochem Pharmacol; 1984 Apr; 33(8):1223-7. PubMed ID: 6712732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoin.
    Renton KW
    J Pharmacol Exp Ther; 1979 Feb; 208(2):267-70. PubMed ID: 762660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of co-administration of interferon inducer, polyriboinosinic acid-polyribocytidylic acid, with SKF 525-A on hepatic drug metabolizing enzymes of rats.
    Matsunaga T; Nagata K; Tanaka E; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1986 Aug; 9(8):638-44. PubMed ID: 3097297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of cytochrome P-450 and alterations of protein metabolism in mice treated with the interferon inducer polyriboinosinic acid X polyribocytidylic acid.
    Gooderham NJ; Mannering GJ
    Arch Biochem Biophys; 1986 Nov; 250(2):418-25. PubMed ID: 2430524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.
    Renton KW; Singh G; Stebbing N
    Biochem Pharmacol; 1984 Dec; 33(23):3899-902. PubMed ID: 6508841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective depression of hepatic cytochrome P-450 hemoprotein by interferon inducers.
    Zerkle TB; Wade AE; Ragland WL
    Biochem Biophys Res Commun; 1980 Sep; 96(1):121-7. PubMed ID: 7437028
    [No Abstract]   [Full Text] [Related]  

  • 20. Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation.
    Singh G; Renton KW; Stebbing N
    Biochem Biophys Res Commun; 1982 Jun; 106(4):1256-61. PubMed ID: 6180750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.